Karol Polom1, Dawid Murawa1, Michał Michalak2, Paweł Murawa1. 1. 1st Surgical Oncology and General Surgery Dept., Wielkopolska Cancer Centre, Garbary 15, Poznan, Poland. 2. Biostatistics Dept., University of Medical Sciences, Poznan, Poland.
Abstract
BACKGROUND: Sentinel node biopsy (SNB) is a gold standard in staging of early breast cancer. Nowadays, routine mapping of lymphatic tract is based on two tracers: human albumin with radioactive technetium, with or without blue dye. Recent years have seen a search for new tracers to examine sentinel node as well as lymphatic network. One of them is indocyanine green (ICG) visible in infrared light. AIM: The aim of this study is to evaluate clinical usage of ICG in comparison with standard tracer, i.e. nanocoll, in SNB of breast cancer patients. MATERIALS AND METHODS: In the 1st Department of Surgical Oncology and General Surgery, Greater Poland Cancer Centre, Poznań, 13 female breast cancer patients have benn operated since September 2010. All these patients had sentinel node biopsy with nanocoll (human albumin with radioactive technetium), and with indocyanine green. The feasibility of this new method was assessed in comparison with the standard nanocoll. RESULTS: A lymphatic network between the place of injection of ICG and sentinel node was seen in infrared light. An area where a sentinel node was possibly located was confirmed by gamma probe. Sensitivity of this method was 100%. CONCLUSION: SNB using ICG is a new, promising diagnostics technique. This procedure is not without drawbacks; nevertheless it opens new horizons in lymphatic network diagnostics.
BACKGROUND: Sentinel node biopsy (SNB) is a gold standard in staging of early breast cancer. Nowadays, routine mapping of lymphatic tract is based on two tracers: human albumin with radioactive technetium, with or without blue dye. Recent years have seen a search for new tracers to examine sentinel node as well as lymphatic network. One of them is indocyanine green (ICG) visible in infrared light. AIM: The aim of this study is to evaluate clinical usage of ICG in comparison with standard tracer, i.e. nanocoll, in SNB of breast cancerpatients. MATERIALS AND METHODS: In the 1st Department of Surgical Oncology and General Surgery, Greater Poland Cancer Centre, Poznań, 13 female breast cancerpatients have benn operated since September 2010. All these patients had sentinel node biopsy with nanocoll (human albumin with radioactive technetium), and with indocyanine green. The feasibility of this new method was assessed in comparison with the standard nanocoll. RESULTS: A lymphatic network between the place of injection of ICG and sentinel node was seen in infrared light. An area where a sentinel node was possibly located was confirmed by gamma probe. Sensitivity of this method was 100%. CONCLUSION: SNB using ICG is a new, promising diagnostics technique. This procedure is not without drawbacks; nevertheless it opens new horizons in lymphatic network diagnostics.
Entities:
Keywords:
Breast cancer; Lymphatic flow; Sentinel node biopsy
Authors: Cherie P Parungo; Shunsuke Ohnishi; Sang-Wook Kim; Sunjee Kim; Rita G Laurence; Edward G Soltesz; Frederick Y Chen; Yolonda L Colson; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni Journal: J Thorac Cardiovasc Surg Date: 2005-04 Impact factor: 5.209
Authors: D Albo; J D Wayne; K K Hunt; T F Rahlfs; S E Singletary; F C Ames; B W Feig; M I Ross; H M Kuerer Journal: Am J Surg Date: 2001-10 Impact factor: 2.565
Authors: Christoph Hirche; Dawid Murawa; Zarah Mohr; Soeren Kneif; Michael Hünerbein Journal: Breast Cancer Res Treat Date: 2010-02-07 Impact factor: 4.872
Authors: M Sekijima; T Tojimbara; S Sato; M Nakamura; T Kawase; K Kai; Y Urashima; I Nakajima; S Fuchinoue; S Teraoka Journal: Transplant Proc Date: 2004-09 Impact factor: 1.066
Authors: Susan L Troyan; Vida Kianzad; Summer L Gibbs-Strauss; Sylvain Gioux; Aya Matsui; Rafiou Oketokoun; Long Ngo; Ali Khamene; Fred Azar; John V Frangioni Journal: Ann Surg Oncol Date: 2009-07-07 Impact factor: 5.344
Authors: John A Olson; Linda M McCall; Peter Beitsch; Pat W Whitworth; Douglas S Reintgen; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Armando E Giuliano Journal: J Clin Oncol Date: 2008-07-20 Impact factor: 44.544
Authors: Zaneta Wareńczak-Florczak; Andrzej Roszak; Krystyna Bratos; Piotr Milecki; Aldona Karczewska-Dzionk; Hanna Włodarczyk Journal: Rep Pract Oncol Radiother Date: 2013-01-15